Efficacy of Only IV Artesunate Versus IV Artesunate Plus IV Quinine in the Treatment of Severe Malaria in Children: A Comparative Study

NACompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

June 30, 2023

Study Completion Date

June 30, 2023

Conditions
Malaria
Interventions
DRUG

IV Artesunate

IV artesunate with a weight-appropriate dosage at 0, 12, 24, and 48 hours and continued 12-hourly for a maximum duration of seven days, with each dose diluted in normal saline and given as an infusion.

DRUG

IV Quinine Hydrochloride

IV Quinine hydrochloride in accordance to weight with loading dose 20mg salt/kg in 10% dextrose infusion followed by 10mg salt/kg infusion 8 hourly for 2 days and for 12 hourly onwards for a maximum of 7 days.

Trial Locations (1)

32200

Allama Iqbal Teaching Hospital, Dera Ghazi Khan

All Listed Sponsors
lead

RESnTEC, Institute of Research

OTHER